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Background: The presence of Lynch syndrome (LS) can bring a lifetime of uncertainty to an entire family as
members adjust to living with a high lifetime cancer risk. The research base on how individuals and families adjust
to genetic-linked diseases following predictive genetic testing has increased our understanding of short-term
impacts but gaps continue to exist in knowledge of important factors that facilitate or impede long-term
adjustment. The failure of existing scales to detect psychosocial adjustment challenges in this population has led
researchers to question the adequate sensitivity of these instruments. Furthermore, we have limited insight into the
role of the family in promoting adjustment.
Methods: The purpose of this study was to develop and initially validate the Psychosocial Adjustment to Hereditary
Diseases (PAHD) scale. This scale consists of two subscales, the Burden of Knowing (BK) and Family Connectedness
(FC). Items for the two subscales were generated from a qualitative data base and tested in a sample of 243
participants from families with LS.
Results: The Multitrait/Multi-Item Analysis Program-Revised (MAP-R) was used to evaluate the psychometric
properties of the PAHD. The findings support the convergent and discriminant validity of the subscales. Construct
validity was confirmed by factor analysis and Cronbach’s alpha supported a strong internal consistency for BK (0.83)
and FC (0.84).
Conclusion: Preliminary testing suggests that the PAHD is a psychometrically sound scale capable of assessing
psychosocial adjustment. We conclude that the PAHD may be a valuable monitoring tool to identify individuals and
families who may require therapeutic interventions.
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Lynch syndrome (LS) is an autosomal dominant disease
characterized by the development of colorectal (CRC)
and extracolonic cancers (Stuckless et al. 2007). Individ-
uals living with LS may be faced with cancer onset in
themselves and other family members, lifelong cancer
screening, extensive treatment regimes and early deaths
of family members. Confirmation of LS through* Correspondence: cway@mun.ca
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reproduction in any medium, provided the orpredictive genetic testing can bring a lifetime of uncer-
tainty to an entire family as members adjust to living
with an indeterminate or evolving disease state. The
research base on how individuals and families adjust to
genetic-linked diseases following predictive genetic
testing has increased our understanding of short-term
impacts but gaps continue to exist in knowledge of
important factors that facilitate or impede long-term
adjustment.
In studies focusing on the impact of genetic-based dis-
eases, the adjustment construct assumes many forms.
Psychological/psychosocial adjustment is used inter-
changeably with psychological/psychosocial functioning,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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others. What is evident from a review of the scientific
literature is a lack of consensus on how psychological
adjustment is defined and operationalized (Wechsler &
Sanchez-Iglesias 2012).
Quantitative studies that focus on hereditary cancer
have primarily assessed short-term psychological func-
tioning (i.e., cancer specific distress, anxiety, and depres-
sion) by using such standardized scales as the State-Trait
Anxiety Inventory (Aktan-Collan et al. 2001; Claes et al.
2004; Collins et al. 2007; Esplen et al. 2001; Esplen et al.
2003; Esplen et al. 2007; Meiser et al. 2004), Impact of
Events Scale (Aktan-Collan et al. 2001; Collins et al.
2007; Esplen et al. 2001; Esplen et al. 2003; Esplen et al.
2007; den Heijer et al. 2011), Hospital Anxiety and
Depression Scale (Collins et al. 2007; Meiser et al. 2004;
den Heijer et al. 2011), and the Center for Epidemiologic
Studies for Depression Scale (Esplen et al. 2001; Esplen
et al. 2003; Esplen et al. 2007). The evidence suggests
that individuals who are part of LS families are not
distressed (intrusive thoughts about cancer, anxiety and
depression) in the short-term post-genetic testing. Pro-
spective studies monitoring changes in psychological
functioning during genetic testing show slight elevations
in carriers distress levels immediately post-testing which
return to baseline levels within a year, but decrease im-
mediately for non-carriers and remain relatively stable
over time (Aktan-Collan et al. 2001; Claes et al. 2004;
Esplen et al. 2001; Murakami et al. 2004). Investigations
of impact for longer periods revealed no differences in
psychosocial outcomes between carriers and non-
carriers at three (Collins et al. 2007; Foster et al. 2007)
or five years post-testing (van Oostrom et al. 2003). The
conclusion of meta-analyses and literature reviews is that
genetic testing for hereditary cancer causes minimal psy-
chological consequences (Bleiker et al. 2003; Braithwaite
et al. 2006; Heshka et al. 2008; Meiser 2005).
Absent from this quantitative research base is pro-
spective data on long-term psychosocial adjustment.
Specifically, there is minimal consideration of the psy-
chosocial and emotional impact of living with hereditary
cancer, personal and family challenges over time and the
role played by family functioning and supports in redu-
cing the impact of hereditary cancer and facilitating ad-
justment. In 2004, our research team administered a
battery of standardized and researcher-developed scales
to a convenience sample of 120 carriers and non-carriers
from LS families in Newfoundland and Labrador at dif-
ferent times post-genetic testing (i.e., 0.1 to 9.2 years).
Baum and colleagues theoretical model of stress and
adaptation (1997) (Baum et al. 1997), previously de-
scribed by Esplen et al. (2007) (Esplen et al. 2007), was
used to guide data collection. Table 1 presents a sum-
mary of the objectives, methods and select findings ofthis initial survey. Study findings revealed that most
respondents were not psychologically distressed (anx-
ious, depressed, intrusive and avoidant thoughts) from
being involved in genetic testing for LS, did not convey
worry/concern about cancer risk for the self/others, were
part of healthy functioning families with adequate
internal strengths, were satisfied with available social
supports, relied equally on emotion-focused and
problem-focused coping, and were satisfied with valued
aspects of life (family, health & functioning, psycho-
logical spiritual and social/economic). Although most
individuals seemed well adjusted, a subgroup had ele-
vated distress levels, compromised family functioning
and lower quality of life.
There is additional support from the literature that a
small, but significant, group of individuals experience
adjustment problems and may be classified as having
borderline distress (Esplen et al. 2007; van Oostrom
et al. 2003; Heshka et al. 2008; Meiser 2005). Problems
with psychological functioning may negatively impact
long-term adjustment, particularly adherence to recom-
mended screening protocols crucial for the prevention
and early detection of cancer. Importantly, the evidence
suggests that individuals with greater social supports
and who belong to families with open communication
are more likely to follow recommended protocols
(Johnson et al. 2002; Keller et al. 2002; McCann et al.
2009), have less psychosocial distress (Claes et al. 2005;
Loader et al. 2002; van Oostrom et al. 2007) and adjust
better over the long-term (den Heijer et al. 2011).
With the sensitivity and specificity of standardized scales
for detecting and monitoring psychosocial adjustment in
this population questioned (Claes et al. 2004; Bleiker et al.
2003), Read, Perry and Duffy (Read et al. 2005) developed
the Psychological Adaptation to Genetic Diseases (PAGIS)
scale to evaluate the efficacy of genetic counseling and
identify individuals requiring additional support. These
researchers propose that psychological adaptation to gen-
etic information is a multidimensional phenomenon com-
prised of non-intrusiveness, support, self-worth, certainty
and self-efficacy. While the PAGIS demonstrated accept-
able internal consistency and content validity in prelimin-
ary testing, there is no further reference to its use in
subsequent studies. The Multidimensional Impact of
Cancer Risk Assessment (MICRA) questionnaire (Cella
et al. 2002) was developed to measure positive and
negative responses to genetic testing for cancer. The
MICRA was initially validated among women at risk for
breast cancer but, to our knowledge, has not been used in
subsequent studies. Despite these disease-specific scales,
there is no empirical evidence suggesting that they are
capable of monitoring how well individuals adjust to
genetic-based diseases in the short-and long-term
(Biesecker & Erby 2008).
Table 1 Objectives, instruments used and results of two preliminary studies undertaken prior to the current study
Study Objectives Instrumentation Results
Phase I:
Survey
1) to investigate psychosocial and behavioral
impact of genetic testing (GT) process for at-
risk individuals in LS families
Standardized scales (Impact of Events Scale
(Horowitz et al. 1979), Centre for
Epidemiologic Studies Depression Scale
(Radloff 1977), State Trait Anxiety Inventory
(Spielberger 1983), McMaster Family
Assessment Device (Epstein et al. 1983),
Family Hardiness Index (McCubbin et al.
1996), Quality of Life Index (Ferrans & Powers
1992), Social Support Questionnaire (Sarason
et al. 1987), Ways of Coping Questionnaire
(Lazarus & Folkman 1984)); researcher-
developed items (medical history, worry/
concerns, demographics, cancer experiences,
reaction to & disclosure of results, screening
& healthy living)
Sample characteristics:
- mean age of 47.4 (SD = 12.9),
range 22 to 78 years
- female (57.5%), carriers (51.7%) of intron
5 splice site mutation (93.3%) and
unaffected (77.5%)
2) to examine key factors (i.e., age, gender,
education, supportive relationships, familial &
personal cancer history, CRC knowledge,
satisfaction with GT decision, time since GT)
associated with difficulties in psychosocial
and behavioral adjustment (reaction to GT
results, perception of risk, willingness to
disclose and to whom) in individuals
affected/unaffected with cancer
- average of 6 years post-genetic testing
Key findings:
- over 33% had moderate to severe
avoidance/intrusive thoughts post-GT;
- small percent above clinical cut-off score
for depression and anxiety
- small percent with quality of life issues
and lower family functioning (role
execution & communication
- no significant impact for time since GT,
gender, age, carrier or cancer status
Phase II:
Qualitative
1) to explore meanings of genetic testing for
individuals at risk for colorectal and related-
cancers in LS families
Semi-structured interviews focused on:
familial cancer experiences (exposure in
close/distant members, first aware of
hereditary link, perceived risk for self,
screening/healthy living motivation) and pre/
post GT (decision-making pre and post
testing, experience with genetic counseling,
reaction to GT results, understanding risk for
self/others, impact on family, role/importance
of supports, adjusting to status & experiences
with health care
Constructs:
- Living in families with a strong history of
hereditary cancer (familial cancer context
& emergence of hereditary link)
2) to understand psychosocial and behavioral
impact of genetic testing for carriers and
non-carriers of LS
- Becoming aware of genetic testing and
living the process (decision-making,
reactions to results, understand risk,
supportiveness of genetic counselors,
disclose results)
3) to use emergent data to improve existing
counseling programs
- Struggling to adjust (personal/family
challenges, family dynamics/support,
barriers/facilitators of adjustment)
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ment challenges for LS families from studies using quan-
titative versus qualitative methodologies can lead to very
different conclusions. Reliance on qualitative methods
helps researchers identify areas of psychosocial impact
that have implications for affective and behavioral out-
comes. The evidence suggests that certain individuals
have difficulty adjusting in the short- and long-term fol-
lowing confirmation of hereditary cancer (Bartuma et al.
2012; Carlsson & Nilbert 2007; Stermer et al. 2004;
Watkins et al. 2011; Hamilton et al. 2009), feel burdened
about communicating genetic risk information to family
members (Hamilton et al. 2009), worry about cancer risk
in others (Bartuma et al. 2012; Carlsson & Nilbert 2007),
perceive that health care system supports post-genetic
testing are inadequate (Stermer et al. 2004; Watkins
et al. 2011), struggle to adhere to recommended screen-
ing protocols (Stermer et al. 2004; Watkins et al. 2011)
and experience difficulty in coping with cancer in the
self/others (Carlsson & Nilbert 2007).
Following the 2004 survey, our research team designed
a grounded theory study to explore the meaning of gen-
etic testing for individuals (n = 39) in LS families anddevelop a greater understanding of psychosocial and be-
havioral impacts for confirmed carriers and non-carriers.
Data collection spanned the years 2004 to 2007. Purpos-
ive samples were recruited from 15 family groupings: a)
2004 survey respondents with an interest in further re-
search (n = 22), b) additional individuals from families
with the intron 5 splice site mutation to augment evolv-
ing family, carrier/non-carrier or affected/non-affected
themes (n =10) and, c) individuals from families with the
more recently identified exon 8 deletion to ensure com-
parability of experiences with intron 5 splice site muta-
tion families (n = 7). Details on the sample and data
analysis have been described elsewhere (Watkins et al.
2011). Semi-structured schedules guided data collection
via face-to face interviews. A second interview con-
firmed the interpretive summaries constructed from
each transcript, augmented gaps in the data and corrob-
orated conceptual categories and properties. Table 1
summarizes study objectives, methods and key findings.
The conceptual model “Confronting and Accepting the
Challenges of Living in Families with Genetic-Linked
Diseases” emerged from analysis of the qualitative data.
The model broadly conjectures that the situational and
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how well individuals accept the hereditary link to cancer,
are motivated to become involved in genetic testing, and
adjust to living with a confirmed presence of LS in the
family in the short- and long-term. The struggling to
adjust construct focuses on psychosocial and behavioral
adjustment in LS families. The findings suggest that
while most individuals acknowledge the importance of
knowing about their cancer risk, some are burdened by
having to manage LS over time (i.e., struggle to adhere
to recommended screening) and having to deal with
cancer episodes in the self and/or others. Importantly,
the impact of LS is not limited to carriers but extends to
all family members. Family functioning and openness of
communications seem critical in helping individuals deal
with the ongoing challenges. Finally, the findings provide
further support for the premise that some individuals in
these families experience difficulty adjusting in the
short- and long-term and, at times, struggle to effectively
manage their disease.
Based on the research literature and quantitative and
qualitative findings from the two projects conducted by
the research team, it was concluded that reliable and valid
clinical tools capable of identifying subgroups of individ-
uals, as well as their families, who may be at-risk for psy-
chosocial and emotional challenges post-genetic testing
are needed for use in genetics clinics. Monitoring tools are
needed to assess adjustment to LS (i.e., positive affect and
well-being, motivation to follow recommended protocols
and modify health behaviors, and the buffering impact of
supports). It was also evident from the literature and our
findings that health care providers tend to not only have
limited insight into the extent of individual and family
burden posed by genetic-based diseases but also fail to
understand the level of support that might be needed to
mitigate long-term effects.
In summary, emphasis on short-term outcomes, without
thorough consideration of the social and familial contexts,
can limit our understanding of long-term psychosocial ad-
justment. We argue that adjustment to hereditary cancer
is broader than psychological outcomes and is an evolving
process that ebbs and flows in response to changing per-
sonal and family experiences in the management of long-
term cancer risk and emergence of cancer in the self and/
or others. Personal and/or family experiences can facilitate
or impede adjustment.
Purpose
The purpose of the current study was to develop and
initially validate a tool for monitoring long-term psycho-
social adjustment. Using the data generated from a
grounded theory study, the Psychosocial Adjustment to
Hereditary Diseases (PAHD) scale was developed as part
of an ethically approved program of research. ThePAHD is designed to assess the personal and family bur-
den of LS and the perceived role of family in buffering
its impact. The specific objectives for this component of
the larger project are to: a) test the feasibility of using
the PAHD scale under variant conditions, b) reduce item
numbers, c) validate subscale and overall scale structure,
and d) examine scaling (rating) methods.Methods
The study was conducted in three phases. Phase I
consisted of item generation and refinement. Phase II
consisted of a pilot study designed to generate data for
preliminary assessment of the psychometric properties of
the PAHD scale. Phase III was designed to generate add-
itional data to facilitate final item selection and initial scale
validation.Phase I: scale development
Interview transcripts from the grounded theory study
provided the data base for scale development. The
grounded theory method facilitated theoretical construct
identification in such a manner that operational indica-
tors defining the properties of each construct could be
used to generate items. Initially, data matrices were cre-
ated for the struggling to adjust construct by collating all
data from the interviews into relevant descriptors of
properties and re-writing the text until a clear decision
trail emerged. Two dominant themes emerged from
these analyses – one focusing on psychosocial adjust-
ment, and the other on behavioral adjustment. The psy-
chosocial adjustment data matrix provided the content
for item generation for the PAHD.
The approach taken to item generation and refinement
consisted of several steps which are summarized in
Table 2. The first step involved item generation and re-
finement. The focus was on identifying potential stems,
reducing the number of stems and reworking and final-
izing the text. The items were grouped into two sub-
scales based on theoretical content. The first subscale
dealt with personal burden issues (i.e., psychosocial dis-
tress and emotional well-being), and the second with
family dynamics and the importance of openness and
supports. At the second step, efforts focused on selecting
the best rating scale format to use with this population.
Following consideration of multiple selection options,
the research team decided to use one rating scale (not at
all, a little bit, moderately, quite a bit, extremely). The
fifth and final steps focused on assessing the scale’s read-
ability and subjecting it to content validation. The read-
ability level of the PAHD was at an acceptable level and
genetic counselors and individuals from LS families vali-
dated the content of the PAHD, as well as the usefulness
of the rating scale.
Table 2 PAHD Scale development
Item stem identification A four-member research team was responsible for item generation and
refinement. Initially, the team became immersed in the data matrices
of the struggling to adjust construct. Independent raters created a profile
of frequency and priority ratings of construct properties and descriptors
(e.g., dwelling on carrier status, positive outlook, concern for young family
members, importance of openness, strain on relations, emotional burden
of suffering & death) by participant and group. Team members used these
profiles to generate item stems for 5 groups and the principal investigator
validated the process. At this stage, the team had 59 potential items.
Item stem reduction Multiple drafts of items for the scale were reviewed and modified by the
researchers. Team meetings were held frequently to collate, prioritize and
refine item stems for potential scale inclusion (emphasis on conciseness,
avoidance of negative wording, ambiguous terminology, jargon, value-laden
words and double-barreled questions). A final set of 17 items were identified
for potential inclusion in the PAHD scale.
Rating scale development Initial rating scales focused on the frequency of occurrence (never, rarely,
sometimes, often, or almost always), and ‘the importance/difficulty/receptiveness
of’ or ‘how satisfied/concerned/confident/certain one was with’ select events/situations
(not at all, a little bit, moderately, quite a bit, extremely). The multiple selection
options made things cumbersome and confusing. The decision was made to rework
the items and use one rating scale. Despite recognizing that a 5-point scale might
not be sufficient for maximum reliability, the group consensus was that it would be
difficult to devise unambiguous additional ordinal adjectives.
Scale readability Several tools (i.e., Flesch-Kincaid Grade Level and Flesch Reading Ease,
Fog index and SMOG) were used to assess the PAHD’s reading level at
less than or equal to Grade 10. Although a grade less than 10 is recommended
to ensure maximum reading ease and material comprehension, the PAHD is
developed to assess the experiences of individuals who have had predictive DNA
testing. These individuals have had repeated exposure to terms such as LS, hereditary
non-polyposis colorectal cancer, carriers/non-carriers, inherited, generations, genetic
and geneticist/genetic counselor. These polysyllabic words and others are used
frequently throughout the scale which does increase the final readability score.
Content validation First, two genetic counselors (GCs) who work with individuals during the genetic
testing process reviewed the PAHD. A brief written synopsis of the conceptual
model and construct definitions, along with a copy of the scales, were given to
the GCs to prepare them for this task. Input was requested on item content relevancy
(extremely, moderately, slightly, or irrelevant) in terms of its ability to measure the properties
of targeted constructs, and effectiveness (very, moderately, poorly or not at all effective) of
the 5-point Likert rating scale for ease of item rating. Minor changes to select items were
made based on their recommendations. Second, the PAHD was administered to individuals
(carrier & non-carrier) who had participated in the survey and qualitative studies. Respondents
were asked to comment on item clarity/relevancy, and rating scale usefulness. No changes
were made at this stage.
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Using a descriptive correlational design with longitudinal
components the PAHD scale was initially tested in indi-
viduals from LS families. The approach to scale testing
was based on the work of Ware and Gandek (Ware &
Gandek 1998), a method used by others (Radwin et al.
2003; Radwin et al. 2005).
Methods
The pilot study was designed to assess the integrity of
subscale and scale structures, item clarity and difficulty,
time required for completion and the feasibility of using
different administrative methods. It also provided data
for a preliminary assessment of the PAHD scale. Following
creation of a descriptive profile for each item (i.e., frequen-
cies, means, standard deviation, skewness and missing
data), a correlation matrix was generated and the strengthand significance of inter-item correlations assessed. A
summary table was constructed of inter-item correlations
falling within set cutoff ranges (i.e., >.40 and .30 to .40)
which was the primary basis for initial subscale item selec-
tion. The final steps included factor analysis and reliability
analysis using Cronbach’s alpha.
Population and sample
The target population was individuals at 50% risk for
inheriting LS who had participated in genetic testing and
informed of their carrier status. Survey respondents were
recruited from families attending the Provincial Medical
Genetics Program of Newfoundland and Labrador
(PMGP-NL). Three large pedigrees with MSH2 muta-
tions on intron 5, exon 8 or exon 4 to 16 have been
identified with 272 carriers and 295 non-carriers con-
firmed and entered into a Cancer Screening Data Base.
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ment for the pilot study which occurred between
February and June of 2008. Of the 120 individuals
contacted, 75 (45 carriers and 30 non-carriers) com-
pleted the survey, resulting in a 62.5% response rate.
Procedure
Ethical approval of the study protocol was granted by
the Human Investigation Committee, Faculty of Medi-
cine, Memorial University as well as Eastern Health
where the PMGP-NL is located. Telephone contact was
initiated with potential respondents to inform them
about the study and ascertain their willingness to receive
additional information. Consenting individuals were
forwarded packages consisting of a cover letter, a brief
summary of the study, two consent forms and the survey
instrument. Following receipt of consent, a follow-up
telephone call was made to determine the preferred
mode of participation (face-to-face, telephone or self-
administered) and to schedule a mutually agreed upon
time for survey completion.
Preliminary results
Importantly, data completeness was similar for all three
methods of PAHD administration, indicating that it is
possible to administer this scale under variant condi-
tions. Preliminary findings indicated that the two sub-
scales appeared to be sensitive enough to measure a
range of factors influencing psychosocial adjustment. For
most items, there was evidence of fair spread across the
response choices. Although factor analysis indicated that
item sampling was less than desired, no further analyses
were pursued until further subject recruitment.
Post-pilot findings
Following recruitment of additional respondents, the
PAHD subscale structure was reexamined. The items
comprising the two subscales were merged with items
from the subscales of the Hereditary Diseases and Gen-
etic Testing (HD-GT), a second scale developed by the
research team to assess the impact of the genetic testing
process (pre, during and post receipt of results), and a
correlational matrix generated. It was anticipated that
this approach would help the research team determine if
meaningful divisions existed between the subscales of
the HD-GT dealing with psychological and emotional
issues from engaging in genetic testing compared to
those of the PAHD which focus on assessment of more
long-term effects. The correlation matrices confirmed
the uniqueness of the PAHD subscales and identified
additional items not loading on any HD-GT subscales
but theoretically similar in content to PAHD items.
The final PAHD scale (Appendix 1) contained two
subscales with 17 items (Table 3). The Burden ofKnowing (BK) and Family Connectedness (FC) subscales
are in line with the psychosocial and emotional compo-
nent of the construct struggling to adjust. The concep-
tual definition highlights the importance of capturing:
a) the perceived personal and/or family burden following
confirmation of LS and b) the role played by family sup-
ports in promoting status acceptance and buffering the
impact of challenges posed by the disease. The BK scale is
comprised of 10 items that recognize the personal and
family aspects of adjustment to hereditary cancer with
higher scores reflecting lesser burden. Additional items
from the HD-GT scale address how the stress of cancer in
younger family members may impact family relations
(BK19_R) and how regular screening may heighten cancer
worries (BK20_R, BK27_R).
Comparatively, the seven-item FC scale assesses family
connectedness with higher scores reflecting the import-
ance of having open discussions and access to resources to
handle the challenges posed by LS. Additional items from
the HD-GT scale address feelings of relief concerning the
availability of genetic testing (FC28) and the role of sup-
portive others in promoting acceptance of healthy behav-
iors (FC29). Two items dealing with emotional well-being
(BK12) and not dwelling on the hereditary cancer (BK13)
failed to load on either subscale but were retained as test
items for future scale administrations.
Phase 3: initial validation
Ongoing recruitment and data collection continued be-
tween July 2008 and July 2010. Data were collected by
face-to-face interviews, telephone interviews and self-
administered surveys. Of the additional 253 individuals
contacted, the scale was administered to another 168
participants. In total, 373 individuals agreed to receive
study materials during the two phases giving a total sam-
ple size of 243 (140 carriers and 103 non-carriers of LS)
and a response rate of 65.1%.
Study respondents were mostly females (63.8%) and from
families with a confirmed MSH2 gene mutation (92.6%). Of
the MSH2 mutations (intron 5 splice site, exon 8 deletion
or exon 4–16 deletion), the dominant type was the intron 5
splice site (62.1%). The remaining participants had muta-
tions in either MLH1 (6.6%) or MLH6 (0.8%). The mean
age was 48.80 (SD =13.60), with a range of 19 to 83 years.
Most participants were carriers (57.60%) but unaffected by
cancer at the time of the study (72.80%). Although study re-
spondents and non-responders were similar with regard to
gender (χ2 (1, N=) = 2.08, p > 0.05), non-responders tended
to be non-carriers (χ2 (1, N=) = 4.79, p < 0.05) and younger
(t (361) = −2.63, p < 0.01) than respondents.
Data analysis
Data were coded and entered into the Statistical Package
for the Social Sciences (SPSS) for analysis. Descriptive
Table 3 Item descriptive statistics for Burden of Knowing (BK) and Family Connectedness (FC) scales (n = 243)
Scale & Items X SD Missing
(%)
Response Values Frequency
0 1 2 3 4
Burden of Knowing (BK) 24.8 8.4 9.5%
• Dwelling on carrier status (BK11_R) 3.1 1.1 0.8 5 24 36 65 111
• Difficulty modifying screening regime (BK14_R) 2.8 1.4 1.6 28 17 41 34 119
• Concerns with non-acceptance by others (BK15_R) 3.4 1.2 2.5 13 14 12 27 171
• Difficulty dealing with young people (BK17_R) 1.8 1.4 3.3 59 43 59 28 46
• Worry about young people’s future (BK18_R) 1.4 1.3 1.2 80 58 49 39 14
• Stress of cancer alters family relations (BK19_R) 2.8 1.3 1.6 17 33 39 40 110
• Screening reminder of personal risk (BK20_R) 2.2 1.5 1.2 50 37 44 39 70
• Concerns about impact on family relations (BK24_R) 3.3 1.2 0.4 13 15 24 25 165
• Worry about burden of cancer on family (BK25_R) 2.3 1.4 0.8 30 44 54 49 64
• Screening heightens cancer worry (BK27_R) 1.9 1.5 0.8 63 46 41 45 46
Family Connectedness (FC) 20.4 5.6 4.5
• Encourage young people to talk about cancer (FC16) 3.0 1.1 1.2 10 18 49 60 103
• Feeling supported facilitates acceptance (FC21) 2.9 1.2 0.4 13 21 41 77 90
• Easy to seek help from family (FC22) 3.0 1.2 0.8 13 18 34 67 109
• Important to openly discuss family cancer (FC23) 3.4 0.8 0.4 0 8 27 62 145
• Caring for others promotes personal acceptance (FC26) 2.3 1.4 1.6 37 31 50 66 55
• Relieved by availability of genetic testing (FC28) 2.9 1.2 1.6 10 21 42 66 100
• Supportive others promotes healthy behaviors (FC29) 3.0 1.1 0.4 11 16 33 78 104
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scores on all study scales. The Multitrait/Multi-Item
Analysis Program-Revised (MAP-R) assessed how well
the PAHD met Likert scaling assumptions (Ware et al.
1997). At the first step, the assumption concerning the
appropriateness of using particular items to create a
summative score (approximate equivalence of means
and variances, use of all response choices in the rating
scale, amount of missing data, and approximate sym-
metry in response distribution) were assessed. At the
second step, a multitrait/multi-item correlation matrix
was generated to assess three additional assumptions
(linearity, item-convergent validity and item-discrimi-
nant validity). At the third step, subscale scores were
assessed in terms of ceiling and floor effects, approxi-
mate symmetry, internal consistency and inter-correla-
tions. Finally, factor analysis examined the construct
validity of the 17-item PAHD scale. The appropriateness
of the factor analytic model was tested using the Kaiser-
Meyer-Olkin (KMO) measure of sampling adequacy and
Bartlett’s test of sphericity. Principal component and
maximum likelihood analysis were the factor extraction
methods. The scree test was used to determine the num-
ber of factors to retain. The preferred rotation method
was orthogonal using varimax rotation.Results
Data quality and item-level summated scale assumptions
Data quality
Item descriptives for the PAHD scale are displayed in
Table 3. Missing data for individual items were random
and minimal, ranging from 0.4% to 3.3%. Although there
is no consensus on what constitutes extensive missing
data (from 10%-40%) on any given item or variable, it is
generally agreed that what is more important is whether
the pattern is systematic or random in nature (El-Masri
& Fox-Wasylyshyn 2005).
The majority of respondents had complete data for the
two subscales. The percent of respondents with
complete data ranged from 90.5% for BK to 95.5% for
FC (data not shown). The minimum and random
amount of missing data for this study suggests that over-
all the scale items were not difficult to understand or in-
terpret (Ware & Gandek 1998).
All response choices were used for most items (94.1%).
The data also depict variability across the rating scale and
approximate a symmetrical distribution. The subscale
items with minimal to no use of certain response choices
were expected. For example, most individuals are expected
to attach high importance to having family members talk
openly about the high cancer risk (FC23).
Table 4 Factor scores and final item to scale correlations
Scale item Factor 1 Factor 2 BK§ FC§
BK11_R .620 -.121 0.58* -0.27
BR14_R .555 -.051 0.45* -0.19
BK15_R .516 -.080 0.46* -0.21
BK17_R .531 -.150 0.49* -0.27
BK18_R .562 -.412 0.55* -0.52
BK19_R .520 -.160 0.48* -0.29
BK20_R .583 -.218 0.55* -0.33
BK24_R .473 -.055 0.42* -0.18
BK25_R .612 -.188 0.56* -0.34
BK27_R .533 -.209 0.50* -0.33
FC16 -.263 .524 -0.38 0.46*
FC21 -.103 .769 -0.32 0.70*
FC22 .001 .706 -0.20 0.59*
FC23 -.180 .798 -0.39 0.73*
FC26 -.237 .503 -0.37 0.51*
FC28 -.162 .537 -0.30 0.48*
FC29 -.180 .600 -0.34 0.58*
Abbreviations: BK = Burden of knowing, FC = Family connectedness.
Extraction Method: Maximum likelihood; Number of factors to retain: Scree
test; Rotation method: Varimax.
§ Item-scale correlation corrected for overlap (relevant item removed from its
scale for correlation). *Denotes item correlations with hypothesized scales.
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Items means and standard deviations within each
subscale are approximately equivalent (Table 3). There
are important exceptions, however, which require further
elaboration. In the BK subscale, items 17, 18 and 27 have
lower mean scores and greater variance than the
remaining items. This finding is expected given that
these items are more focused on personal worries and
interaction difficulties. The higher mean scores and
lower variances observed for items 11, 15 and 24 were
also expected since their content focuses on the personal
and family implications of knowing one’s carrier status
and dealing with LS. Similarly, the higher score and
lower variance observed for item 23 of the FC subscale
was also expected as most individuals attach importance
to open discussion of high cancer risk among family
members.
Scale level assumptions
Item internal consistency
Table 4 outlines Pearson item-scale correlations corrected
for item overlap (Ware & Gandek 1998; Howard & Fore-
hand 1962). Item-scale correlations were used to examine
the relationship of each item to its hypothesized scale
(i.e., internal consistency). Correlations for all items within
their respective scales are larger than correlations between
items and competing scales. In addition, all item-scale cor-
relations are 0.42 or larger indicating a substantial and sat-
isfactory item internal consistency (Ware & Gandek 1998).
Equality of item-scale correlations
This assumption addresses the proximity of values for all
item-scale correlations within a hypothesized scale. The
best scale contains item-scale correlations that are roughly
equal and ideally fall within the 0.40 to 0.70 range (Ware
& Gandek 1998). The reader is again referred to the
corrected item-total correlations for individual items and
their subscales in the columns with asterisks in Table 4.
For the majority of items in the two subscales, the
corrected-item total correlations fall within an accept-
able range. There are some exceptions however. The
items that appear to be contributing more to their vari-
ous scales than other items include items 21 and 23 of
the FC subscale. These items deal with emotional con-
tent which may be responsible for the observed discrep-
ancies. This finding is expected to a degree since item
content is focused on the importance of feeling sup-
ported by family/friends in coming to terms with being a
carrier/non-carrier and the importance of family mem-
bers openly discussing the cancer risk.
Item discriminant validity
This assumption examines the strength of item correla-
tions with other scales with the objective that each itemhas a stronger correlation with its hypothesized scale than
with other related scales. Study findings are summarized
in Table 4. Four score categories (−1, -2, +1 or +2) are
possible for each test with the standard error of correl-
ation setting the criterion. Values of −1 and −2 indicate
that an item has failed the test of item discriminant valid-
ity. In this study, all item scale discriminant tests (data not
shown) scored +2 indicating item-scale correlations were
significantly higher for the hypothesized scale than for a
competing scale.
Scale level descriptive statistics
Total subscale scores were constructed for each partici-
pant following confirmation of item scaling assumptions.
Consideration was first given to the impact of select
sample characteristics on subscale scores. At the second
step, the properties of the subscales were examined with
special attention given to the logic of mean and standard
deviation scores.
Comparability of scale scores
It was hypothesized that subscale means should be ap-
proximately equal within the sample based on demo-
graphic and illness-related characteristics. The reader is
reminded that the BK subscale is reversed scored. The
t-test of difference and correlation tests assessed the im-
pact of select factors on subscale scores. No significant
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presence, age or time since genetic testing (p > .05) (data
not shown). However, females tended to report signifi-
cantly higher levels of burden than men on the BK
subscale. Women also had significantly higher mean
scores than men on the FC subscale suggesting that
women attach greater importance to having access to
family support and resources in dealing with LS.Scale properties
Subscale means, standard deviations, lowest and highest
scores and score ranges were examined for both raw and
transformed scores. The focus here was on the logic be-
hind the distribution of subscale scores. For the BK
subscale, a higher score is reflective of less personal and
family burden associated with adjustment to hereditary
cancer. Higher scores on the FC subscale are reflective
of better family connectedness in dealing with the chal-
lenges posed by LS.
The pattern of mean scores and standard deviations
for each subscale is summarized in Table 5. The
transformed mean score (62 ± 20.9) on BK suggests that
participants, on average, reported experiencing a little to
moderate amount of burden. The transformed mean
score (73 ± 19.9) on the FC subscale suggests that re-
spondents, on average, gave high ratings to having open
discussions and access to family resources/supports to
handle the challenges posed by LS.Reliability and validity of PAHD
Cronbach’s alpha coefficient was used to assess internal
consistency. Correlations among the subscales are useful
preliminary measures of the construct validity of the
entire scale. Reliability ranged from 0.83 for BK to 0.84
for FC. The reliability coefficients were above the mini-
mum 0.70 level suggested for group level comparisons
(Nunnally & Bernstein 1994). These findings suggest
that the two subscales have good internal consistency.
The findings support the premise that each of the two
subscales is making a distinct contribution to the overall
PAHD scale. The alpha coefficients for each of the sub-
scales are larger than the Pearson’s r values (data not
shown). The subscales of the PAHD depict significant
low to moderate, negative correlations with each other.
That is, higher levels of family connectedness areTable 5 Descriptive statistics using transformed scores for
Burden of Knowing (BK) and Family Connectedness (FC)
scales
Scale Mean SD Range % Missing % At floor % At ceiling
BK 62.0 20.9 0-100 9.5 0.5 0.5
FC 73.0 19.9 14.3-100 4.5 0.4 6.5associated with lower levels of personal and family bur-
den in adjusting to LS.
The 243 participants provided an adequate sample for
conducting factor analysis of the 17-item PAHD scale.
The KMO value was 0.85 exceeding the minimally accept-
able level of 0.6 (Kaiser 1970). Bartlett’s test of sphericity
was also acceptable (p = 0.000), indicating the feasibility of
using a factor model for the analysis. These two measures
of psychometric adequacy suggested that the PAHD cor-
relation matrix was suitable for factor analysis.
Factor analysis revealed four distinct dimensions.
Based on the scree plot, it was possible to force a two-
factor solution which accounted for 45.4% of the vari-
ance (Table 4). The first 10-item factor, BK, included
items with loadings greater than 0.47. The scale had a
reliability of 0.83. Item BK18_R appeared to be factori-
ally complex. While its highest loading is on factor 1, it
also loads on factor 2. Using ± .33 as the minimal level
of practical significance for factor loadings (Ho 2006),
our team could either delete the item from the analysis
or rewrite it (Norman & Streiner 2008). At this stage of
scale development, it was decided to retain the item for
further investigation. The second 7-item factor, Family
Connectedness, included items with loadings greater
than 0.50. The scale had a reliability of 0.84. Overall,
the factor analysis supports the qualitative and quanti-
tative findings.
Discussion
The PAHD scale was the outcome of a program of re-
search that relied on survey and qualitative methods to
inform the research team about psychosocial adjustment
challenges in LS families. The scale was developed from
content defining the struggling to adjust construct of a
theoretical model generated from grounded theory. A
four-member research team developed the scale by gen-
erating a large set of potential items, refining the items,
and validating item content using experts and individ-
uals from families with hereditary cancer.
By developing the PAHD from a qualitative data base,
the content is steeped in the personal experiences of indi-
viduals from families with hereditary cancer. Various
authors argue that instrument item-content generated
from qualitative data is more likely to capture the experi-
ences of targeted groups (Coyle & Williams 2000;
McAllister 2001). It is also argued that clinical tools devel-
oped in this manner have better content and face validity
and excellent psychometric properties (Gilgun 2004).
The current study provides initial evidence to support
the psychometric properties of the PAHD scale. The
pilot study supported the relevancy of item content and
logic of the two subscale structure. Application of the
MAP-R to findings from the larger sample suggests that
the PAHD has acceptable internal consistency reliability,
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(Ware et al. 1997). Intrascale correlations compared with
scale Cronbach’s alphas indicate that the two subscales
(BK and FC) of the PAHD are measuring distinct but in-
terrelated concepts.
The BK scale is intended to capture the subjective per-
ception of individual and family burden from knowing
about the presence of LS in the family. The mean BK
score suggests that participants, on average, reported ex-
periencing a little to moderate burden. Although no sig-
nificant differences were observed for carrier and affected
status or time since genetic testing, women tended to re-
port higher levels of burden than men. Despite the limited
insight from existing literature on the depth and scope of
the long-term struggles of individuals living within LS
families, several authors acknowledge that their complex-
ity is shaped by the interaction of experiential cancer-
based knowledge from the past and present as well as
individual coping styles (Bleiker et al. 2003; McAllister
2001; d’Agincourt-Canning 2005; Kenen et al. 2003;
McAllister 2002; Rolland & Williams 2005). Results from
the current study support previous qualitative findings
that a subgroup of individuals experience psychosocial dis-
tress in the long-term following confirmation of hereditary
cancer (Watkins et al. 2011; Hamilton et al. 2009).
The second subscale, FC, is intended to capture the
importance of having access to resources and family
supports in sharing the burden and challenges of heredi-
tary cancer. The mean score suggests that respondents,
on average, gave high ratings to the presence of support-
ive family structures. Again study findings did not vary
based on carrier and affected status or time since genetic
testing, but women tended to value family supports
more than men.
The low to moderate correlation between the two sub-
scales support the multidimensional nature of the PAHD
scale. Given that the correlations between the two scales
of the PAHD are less than their reliability coefficients,
there is evidence of unique reliable variance measured
by each scale. A major premise of the model from which
the PAHD was developed is that living in families char-
acterized by open, supportive relationships facilitates
psychosocial and emotional adjustment and decreases
the burden associated with the presence of hereditary
cancer. Therefore, it was expected that the subscales of
the PAHD would correlate well with each other.
The findings suggest that individuals with more per-
ceived support from family and friends tended to be less
burdened from dealing with the challenges posed by her-
editary cancer in the family. The value of the strength
and stability of family support systems for facilitating
positive coping and adjustment at the individual and
family level is receiving increased attention in the re-
search literature on genetic-based diseases (van Oostromet al. 2003; McAllister 2001; Kenen et al. 2003; Rolland
& Williams 2005).
The results of these analyses provide support for the
uniqueness of the PAHD subscales and add further cre-
dence to its validity. Future studies are needed to deter-
mine the scale’s potential for monitoring the long-term
psychosocial adjustment.Limitations
While the initial validation results are promising, there
are a number of limitations to consider. First the study
was cross-sectional and thus it is not possible to evaluate
the scale’s monitoring capabilities. Second, the use of
mixed methods for data collection may have influenced
the findings. Further, the responders were significantly
older than non-responders thus potentially limiting our
knowledge of the experiences of younger individuals.
Finally, it is also possible that the higher proportion of
non-carriers among the non-responders may have al-
tered the findings.Conclusion
The use of qualitative data to develop the PAHD has pro-
duced a scale that is steeped in the experiences of individ-
uals and families with hereditary cancer. Initial testing
suggests that the scale is psychometrically sound and cap-
able of assessing psychosocial adjustment. Although study
results support other findings reported in the literature,
the PAHD scale is unique in that it is specific to hereditary
cancer. As a clinical monitoring tool for use following gen-
etic testing, it has the potential to identify those who are
experiencing psychosocial challenges and who may require
additional support for optimal adjustment.
The PAHD scale has been adapted and is being piloted
in a second population with hereditary disease. A focus of
this pilot is to examine the psychosocial impact of
arrhythmogenic right ventricular cardiomyopathy (ARVC)
on individuals and families post-genetic testing. The next
stage of research for the project team will focus on
implementing the PAHD scale in Community Familial
Cancer Genetics Clinics throughout Newfoundland and
Labrador.Appendix 1
Psychosocial Adjustment to Hereditary Diseases (PAHD) Scale.
We are interested in the long-term effects of a con-
firmed HNPCC or Lynch syndrome presence in families.
Everyone goes through periods of trying to make sense
of inner feelings about what the future might hold for
the self and other family members. Using the scale given,
you are asked to rate how well each statement reflects
your situation (Table 6).
Table 6 Psychosocial Adjustment to Hereditary Diseases (PAHD) Scale
0 Not
at all
1 A
little
bit
2
Moderately
3 Quite
a bit
4
Extremely
I think about being a carrier/non-carrier more than I should.
(BK11_R)………..
0 1 2 3 4
I try to be positive about my future health and overall well-being.
(BK12) .........
0 1 2 3 4
It is important for my future health not to dwell on the hereditary
link to cancer in the family. (BK13) ............................................................................................
0 1 2 3 4
It was hard changing how often I had to screen for cancer.
(BK14_R) ................
0 1 2 3 4
It bothers me when others do not accept my carrier/non-carrier status.
(BK15_R) ..............................................................................................................
0 1 2 3 4
Younger people need to be encouraged to talk about all the cancer in
the family. (FC16) ......................................................................................................
0 1 2 3 4
I find it hard dealing with younger family members who get cancer.
(BK17_R)
0 1 2 3 4
I worry about what the future might hold for younger family members.
(BK18_R) ..............................................................................................................
0 1 2 3 4
The stress of so much cancer in the family, more so in younger members,
pulled some of us closer together but pushed others apart. (BK19_R) ................
0 1 2 3 4
Regular screening for cancer became a constant reminder of my cancer risk by being in this
family. (BK20_R) ............................................................................
0 1 2 3 4
Some families handle the challenges of a strong cancer presence better than others do. We
want to know how well individuals in your family support one another. Using the scale
given, you are asked to rate how well each statement reflects your situation.
Feeling supported by family and friends has helped me accept being a carrier/non-carrier.
(FC21) ....................................................................................
0 1 2 3 4
I find it easy to seek help from family members when I need it. (FC 22) ............ 0 1 2 3 4
It is important for everyone to talk openly about the high cancer risk
in the family. (FC23) .......................................................................................................
0 1 2 3 4
I am concerned that the presence of hereditary cancer has hurt family relations.
(BK24_R) ..............................................................................................................
0 1 2 3 4
I worry that all the suffering and death from cancer is placing too
much burden on family members. (BK25_R) .............................................................................
0 1 2 3 4
Providing care to other family members with cancer has helped me
become more accepting of my future. (FC26) ...................................................................
0 1 2 3 4
With so much cancer in the family, I worried that something would
show up on my next screening test. (BK27_R) ........................................................................
0 1 2 3 4
When I knew there was a test to see if my family had the cancer gene,
I was relieved. (FC28) ....................................................................................................
0 1 2 3 4
Encouragement and support from family and friends helps one accept
the need for health living and cancer screening. (FC29) .....................................................
0 1 2 3 4
Note: R indicates items to be reverse coded. BK = Burden of Knowing. FC = Family Connectedness.
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